Barclays
MDLN icon

Barclays’s Medline Inc MDLN Stock Holding History

Barclays’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$31.8M Buy
917,828
+662,809
+260% +$24.2M 0.01% 994
2026
Q2 		$10.1M Buy
255,019
+186,140
+270% +$7.5M ﹤0.01% 1478
2026
Q1 		$3.07M Buy
+68,879
New +$3.04M ﹤0.01% 2107

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
H&F Corporate Investors X
H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Barclays's MDLN Position: Q3 2026 in Review

Barclays increased its Medline Inc (MDLN) stake by 260% in Q3 2026, buying an estimated $24.2M and bringing the position to 917,828 shares worth $31.8M. The position accounts for 0.01% of the portfolio, ranked #994.

Barclays first reported a position in MDLN in Q1 2026 and has held it in 3 quarters since. 315 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Barclays held 917,828 shares of Medline Inc worth $31.8M as of Q3 2026.
  • Barclays bought 662,809 Medline Inc shares in Q3 2026, an estimated $24.2M.
  • Medline Inc made up 0.01% of Barclays's portfolio in Q3 2026, its #994 holding.
  • Barclays first reported a position in Medline Inc in Q1 2026 and has held it in 3 quarters since.
  • 315 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.